Citeline Podcasts

“Powerful Yet Unexplored”: Commit Biologics Tackles The Complement System

20 May 2025

Contributed by Lukas

Mikkel Wandahl Pederson, CEO and chief scientific officer at Commit Biologics, discussed the company’s mission to harness the powerful complement sy...

제약바이오딜 투자수익률 하락…시장 불안정으로 상황 악화될 수도 (Korean-language podcast)

20 May 2025

Contributed by Lukas

바이오기업 가치상승으로 일부 딜 (deal)의 경우 빅파마의 투자수익률 (ROI)이 거의 없는 상황이지만, 특정 전략으로...

Taking Real-World Evidence Seriously, With IQVIA Consumer Health’s Volker Spitzer

20 May 2025

Contributed by Lukas

While few doubt the opportunity represented by real-world evidence, some concerns remain about its validity compared to traditional forms of clinical ...

Scrip's Five Must-Know Things - 19 May 2025

19 May 2025

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the business week ended 16 May 2025. In this episode: Trump’s executive order m...

China Biopharma Podcast - 14 May 2025 (Chinese language)

14 May 2025

Contributed by Lukas

在本期中国生物技术播客中，Dexter Yan回顾了他在4月的美国癌症研究协会年会（AACR）举办前和再鼎医药总裁及全球...

Scrip's Five Must-Know Things - 12 May 2025

12 May 2025

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the business week ended 9 May 2025. In this episode: industry makes its case to T...

Drug Fix: A New Director For US FDA’s Biologics Center, Guidance Production Slowdowns

09 May 2025

Contributed by Lukas

Pink Sheet Executive Editor Derrick Gingery, Senior Editor Sue Sutter and Editor-in-Chief Nielsen Hobbs consider early excitement and concern about Vi...

Scrip's Five Must-Know Things - 7 May 2025

07 May 2025

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the business week ended 2 May 2025. In this episode: AstraZeneca CEO cautions Eur...

Everything You Wanted To Know About Real World Evidence, With IQVIA’s Volker Spitzer

06 May 2025

Contributed by Lukas

The potential for real world evidence (RWE) is huge, according to enthusiasts, but to the uninitiated it can seem like a complicated and forbidding su...

OPPI’s Matai On India’s IPR Regime: Progress, Pain Points, Possibilities

05 May 2025

Contributed by Lukas

Anil Matai, director general, Organization of Pharmaceutical Producers of India, discusses the evolving intellectual property landscape in India post ...

Drug Fix: Vaccine Review Political Interference, Missed Deadlines A Harbinger Of US FDA Problems?

02 May 2025

Contributed by Lukas

Pink Sheet Executive Editor Derrick Gingery, Senior Writer Sarah Karlin-Smith, Senior Editor Sue Sutter and Editor in Chief Nielsen Hobbs consider the...

Scrip M&A Podcast: Will the FDA Staff Cuts Affect Biopharma M&A Activity?

01 May 2025

Contributed by Lukas

Scrip senior writer Joseph Haas discusses the potential impact of the recent FDA staff cuts with attorneys Andrew Goodman of Paul Hastings LLP and Ala...

Conference Catch-Up: BIO-Europe 2025

01 May 2025

Contributed by Lukas

In this episode, we recap the key takeaways from BIO-Europe 2025, held in Milan, Italy, in March 2025, with Trajko Spasenovski, Vice President of Stra...

Highlights from AAN 2025

30 Apr 2025

Contributed by Lukas

Emma Wille and Summer Colling discuss the 2025 American Academy of Neurology (AAN) conference with CNS and I&I analysts Wen-Yu Huang, Joseph Jacob and...

Aragen CEO On Funding Cuts At NIH, Biotechs And Likely US Pharma Tariffs

29 Apr 2025

Contributed by Lukas

Aragen Life Sciences’s CEO Manni Kantipudi - also former CIO of Intel Asia - speaks with Citeline’s senior editor Vibha Ravi about the changing gl...

Scrip's Five Must-Know Things - 28 April 2025

28 Apr 2025

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the business week ended 25 April 2025. In this episode: 2024’s top-selling drug...

Drug Fix: More US FDA Departures, Makary On Combined AE Database, ‘Conditional’ Approval

25 Apr 2025

Contributed by Lukas

Pink Sheet Executive Editor Derrick Gingery, Senior Writer Sarah Karlin-Smith and Senior Editor Sue Sutter discuss the impact of the departures of sev...

Precision Medicine in Liver Treatment: The Ochre Bio Approach

23 Apr 2025

Contributed by Lukas

Ochre Bio co-founder and CSO Quin Wills spoke with In Vivo about the UK-based company's novel approach to finding and validating RNA therapies for chr...

Scrip's Five Must-Know Things - 21 April 2025

21 Apr 2025

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the business week ended 18 April 2025. In this episode: Trump’s drug pricing ex...

Brands, Brexit And New Self-Care Business Models, With PAGB’s Michelle Riddalls

18 Apr 2025

Contributed by Lukas

Summary: At the heart of any successful self-care business is a portfolio of recognizable and trusted consumer health brands. These brands could play ...

Scrip's Five Must-Know Things - 14 April 2025

14 Apr 2025

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the business week ended 11 April 2025. In this episode: Trump’s tariff rollerco...

미국 관세 롤러코스터에 제약업계는 여전히 불안 (Korean-language podcast)

11 Apr 2025

Contributed by Lukas

미국이 수입 의약품에 관세를 부과할 가능성은 여전하지만, 트럼프의 최근 발표로 인해 이를 시행하는 데 시간이...

Evolving The UK Consumer Health Industry, With PAGB’s Michelle Riddalls

07 Apr 2025

Contributed by Lukas

Exerting maximum influence on stakeholders, helping companies navigate regulatory complexity and promoting industry best practice are three big jobs t...

Scrip's Five Must-Know Things - 7 April 2025

07 Apr 2025

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the business week ended 4 April 2025. In this episode: pharma dodges tariffs for ...

Drug Fix: Understanding The US FDA Reduction-In-Force And Its Long-Term Impact

04 Apr 2025

Contributed by Lukas

Pink Sheet Executive Editor Derrick Gingery, Senior Writer Sarah Karlin-Smith, Senior Editor Sue Sutter, and Editor-in-Chief Nielsen Hobbs discuss the...

CEO Nicolas Poirier on OSE Immunotherapeutics Latest IL-7 Data

03 Apr 2025

Contributed by Lukas

OSE Immunotherapeutics' CEO Nicolas Poirier talks about the company's IL-7 receptor agonist, lusvertikimab, recent data presented at The European Croh...

Digital Health Roundup: Intuitive CEO Exec Chat, Patient Monitoring, Exer Labs Woes, Roche New NGS Prototype

02 Apr 2025

Contributed by Lukas

In this week’s Digital Health Roundup, Medtech Insight’s Marion Webb highlights her interview with Gary Guthart, CEO of Intuitive Surgical about t...

Scrip's Five Must-Know Things - 31 March 2025

31 Mar 2025

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the business week ended 28 March 2025. In this episode: Merck & Co. licenses Heng...

Drug Fix: Understanding The Impact Of The Latest HHS Layoffs On The US FDA

28 Mar 2025

Contributed by Lukas

Introduction: Pink Sheet Executive Editor Derrick Gingery, Senior Writer Sarah Karlin-Smith, and Senior Editor Sue Sutter discuss the impact of the 3,...

Innovative Oncology, A Conversation with iOnctura

28 Mar 2025

Contributed by Lukas

In Vivo spoke with UK biotech CEO Catherine Pickering about developing innovative therapies for challenging cancer types, the progress of iOntura's le...

Podcast: Heranova CMO Advocates For Endometriosis Awareness: “Pain Is Not Normal”

26 Mar 2025

Contributed by Lukas

Farideh Bischoff, chief medical officer of Heranova Lifesciences, discusses the urgent need for better diagnostic options and the latest innovations t...

What To Expect From The 61st AESGP Annual Meeting, With AESGP’s Jurate Švarcaite

24 Mar 2025

Contributed by Lukas

Europe’s self-care industry leaders, policymakers and stakeholders are heading to Warsaw, Poland between the 4th and 6th June this year for the Asso...

Scrip's Five Must-Know Things - 24 March 2025

24 Mar 2025

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the business week ended 21 March 2025. In this episode: Pfizer tops pharma leader...

Drug Fix: US FDA Productivity Complaints Emerge, Internal Return To Office Headaches

21 Mar 2025

Contributed by Lukas

Pink Sheet Executive Editor Derrick Gingery, Senior Writer Sarah Karlin-Smith and Editor-in-Chief Nielsen Hobbs discuss industry stakeholders’ compl...

Scrip's Five Must-Know Things - 17 March 2025

17 Mar 2025

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the business week ended 14 March 2025. In this episode: Roche’s big new obesity...

Drug Fix: Buyouts, Departures and Other US FDA Chaos

14 Mar 2025

Contributed by Lukas

Pink Sheet Executive Editor Derrick Gingery, Senior Writer Sarah Karlin-Smith and Editor-in-Chief Nielsen Hobbs discuss the US Food and Drug Administr...

The Generics Bulletin Podcast: Stelara Biosimilar Launches In The US

11 Mar 2025

Contributed by Lukas

Generics Bulletin editors Dave Wallace and Dean Rudge discuss the latest updates on Stelara (ustekinumab) biosimilars in the US, including recent laun...

Scrip M&A Podcast: Looking at M&A activity as Q1 2025 nears a close.

11 Mar 2025

Contributed by Lukas

Scrip senior writer Joseph Haas discusses the latest biopharmaceutical merger-and-acquisition activity and trends with attorneys Jessica Bisignano and...

Vaccines, Viruses & Variants: The State of COVID-19 & Flu in 2025

11 Mar 2025

Contributed by Lukas

Summer Colling and Emma Wille speak with Datamonitor Healthcare's infectious disease analysts Charlotte Holmes and Natasha Boliter to discuss the late...

Scrip's Five Must-Know Things - 10 March 2025

10 Mar 2025

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the business week ended 7 March 2025. In this episode: low-cost Wegovy an alterna...

Women’s Health Innovation And Beyond, With Maxwellia’s Anna Maxwell

10 Mar 2025

Contributed by Lukas

Summary: The UK’s Maxwellia has been on quite a journey, from “switch-in-a-box” start-up to a consumer healthcare company in its own right, laun...

Grove AI and Grace, An Agentic AI For Clinical Trial Engagement

07 Mar 2025

Contributed by Lukas

In Vivo spoke with Tran Le and Sohit Gatiganti, co-founders of Grove AI and developers of Grace, a voice-based agentic AI that streamlines clinical tr...

Drug Fix: What We Learned From US FDA Commissioner Nominee Makary’s Confirmation Hearing?

07 Mar 2025

Contributed by Lukas

Pink Sheet Executive Editor Derrick Gingery, Senior Writer Sarah Karlin-Smith, Senior Editor Sue Sutter, and Editor-in-Chief Nielsen Hobbs discuss the...

【3分で解説 世界のファーマ】第23回 トランプ関税 製薬への影響は (Japanese-language podcast)

07 Mar 2025

Contributed by Lukas

世界の製薬ビジネスを伝える「Scrip」と、各国で変化する製薬関連の規制に特化した「Pink Sheet」。普段は英語で...

트럼프의 관세 인상에 대한 엇갈린 반응 (Korean-language podcast)

06 Mar 2025

Contributed by Lukas

트럼프의 관세 조치에 따른 미국시장 영향과 글로벌 빅파마들의 반응에 대한 Scrip 기사를 요약한 내용입니다. http...

The Challenge Of Innovating In A Changing OTC Industry With AdverCheck’s James Walmsley

03 Mar 2025

Contributed by Lukas

The consumer healthcare industry is changing. Companies are separating from their pharmaceutical parents and brands are shifting from therapeutic solu...

Scrip's Five Must-Know Things - 3 March 2025

03 Mar 2025

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the business week ended 28 February 2025. In this episode: which big companies fa...

Drug Fix: Laid Off US FDA Staff Called Back, Vaccine Adcomm Cancelled, Lilly’s Manufacturing Push

28 Feb 2025

Contributed by Lukas

Pink Sheet Executive Editor Derrick Gingery, Senior Writer Sarah Karlin-Smith and Editor-in-Chief Nielsen Hobbs, as well as Medtech Insight Managing E...

Scrip's Five Must-Know Things - 25 February 2025

25 Feb 2025

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the business week ended 21 February 2025. In this episode: 2025’S biggest launc...

Why OTC Firms Should Care About Rx Advertising, With AdverCheck’s James Walmsley

24 Feb 2025

Contributed by Lukas

UK law prohibits the advertising of prescription-only medicines. Nevertheless, some online pharmacies are marketing Rx drugs from “skinny jabs” to...

Drug Fix: Understanding the US FDA Layoffs And Their Impact On Industry

21 Feb 2025

Contributed by Lukas

Pink Sheet Executive Editor Derrick Gingery, Senior Writer Sarah Karlin-Smith, Senior Editor Sue Sutter, and Editor-in-Chief Nielsen Hobbs, as well as...

Scrip's Five Must-Know Things - 18 February 2025

18 Feb 2025

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the business week ended 14 February 2025. In this episode: delayed take-off for M...

Drug Fix: RFK’s First Actions, Pitch To Extend Current US FDA User Fee Agreement, More Trump Impacts

14 Feb 2025

Contributed by Lukas

Pink Sheet Executive Editor Derrick Gingery, Editor-in-Chief Nielsen Hobbs, and special guest Michael McCaughan of Prevision Policy look at new Health...

Podcast: JPM Tracked and Unpacked

13 Feb 2025

Contributed by Lukas

Citeline’s expert panel of reporters and analysts unpack the biggest deals, trends, and innovations from the JP Morgan Healthcare Conference. Discov...

Scrip이 묻다... 2025년 제약바이오 산업의 미래는? 세계 정치 변화의 영향 (Korean-language podcast)

12 Feb 2025

Contributed by Lukas

트럼프 미 대통령의 재당선과 지정학적 불안요소가 제약바이오 시장과 기업에 어떤 영향을 미칠까? Scrip의 전문가...

Getting Creative In Consumer Health, With All Creative’s Beverley Law

10 Feb 2025

Contributed by Lukas

Creativity can sometimes be about discovering what in retrospect seems obvious, like shoes that are shaped to fit our feet, marketing expert Beverley ...

Scrip's Five Must-Know Things - 10 February 2025

10 Feb 2025

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the business week ended 7 February 2025. In this episode: Novo outlines CagriSema...

Drug Fix: Kennedy’s Assurances To Gain HHS Nod, US FDA Coms Freeze Continues Thawing

07 Feb 2025

Contributed by Lukas

Introduction: Pink Sheet Executive Editor Derrick Gingery, Senior Writer Sarah Karlin-Smith, Senior Editor Sue Sutter and Editor-in-Chief Nielsen Hobb...

Harness Therapeutics CEO Talks Somatic Expansion for Neurodegeneration

03 Feb 2025

Contributed by Lukas

Harness Therapeutics' CEO talked to In Vivo about the company's scientific strategy, and its plans for expansion and partnering in the neurodegenerati...

Scrip's Five Must-Know Things

03 Feb 2025

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the business week ended 31 January 2025. In this episode: biopharma VC fundraisin...

Datamonitor Healthcare Podcast: Epidemiology in the Age of Real World Data and AI

31 Jan 2025

Contributed by Lukas

Summer Colling and Emma Wille speak with epidemiologists Ridwaan Ibrahim and Lucia Rodriguez-Garcia about the recent ISPOR conference. Ridwaan and Luc...

Drug Fix: President Trump’s Policies Begin Changing The US FDA, Kennedy’s Hill Hearings

31 Jan 2025

Contributed by Lukas

Pink Sheet Executive Editor Derrick Gingery, Senior Writer Sarah Karlin-Smith, Senior Editor Sue Sutter, and Editor-in-Chief Nielsen Hobbs discuss the...

Scrip's Five Must-Know Things - 27 January 2025

27 Jan 2025

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the business week ended 24 January 2025. In this episode: semaglutide in 2027 Med...

Drug Fix: Concerns and Questions As Trump Administration Takes Control Of US FDA

24 Jan 2025

Contributed by Lukas

Pink Sheet reporter and editors try to answer some emerging questions about the US Food and Drug Administration now that President Donald Trump has ta...

Fauna Bio: Gleaning Therapeutic Insights From Animals

20 Jan 2025

Contributed by Lukas

In Vivo speaks with Ashley Zender, CEO of Fauna Bio, a company using AI to identify drug targets based on natural disease resistance in animals. The c...

Scrip's Five Must-Know Things - 20 January 2025

20 Jan 2025

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the business week ended 17 January 2025. In this episode: a look at JPM; J&J’s ...

A “Game Changer” For The High-Risk MDS Patient Population

17 Jan 2025

Contributed by Lukas

Juho Jalkanen, CEO of Faron Pharma, discusses the importance of addressing unmet medical needs in cancer through breaking treatment resistance and dev...

Drug Fix: US FDA And Trump’s Reforms, CDER Director Parting Comments, 2024 Approval Trends

17 Jan 2025

Contributed by Lukas

Pink Sheet editors consider ex-FDA officials’ advice for the Trump Administration on implementing FDA reforms (:24), comments CDER Director Patrizia...

Scrip's Five Must-Know Things - 14 January 2025

14 Jan 2025

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the business week ended 10 January 2025. In this episode: key themes for JPM; 202...

Drug Fix: CDER Director Retires, US FDA Guidance ‘Blizzard,’ Rare Pediatric Disease Program Hangs On

10 Jan 2025

Contributed by Lukas

Pink Sheet editors discuss Center for Drug Evaluation and Research Director Patrizia Cavazzoni’s surprising retirement announcement (:32), the impor...

2025년 JP모건 헬스케어 컨퍼런스의 주요 주제는? (Korean-language podcast)

09 Jan 2025

Contributed by Lukas

트럼프 대통령의 취임 직전 열리는 2025년 JP모건 헬스케어 컨퍼런스에서 라이센스딜 및 M&A 뿐 아니라 미국 정치와...

Pre-JPM Biotech Dealmaking Roundtable

07 Jan 2025

Contributed by Lukas

As we enter 2025, In Vivo convened a group of biotech executives for a wide-ranging conversation about dealmaking this year and the challenges and opp...

Digital Health Roundup: 2025 Will See More AI/GenAI Adoption In Medtech, FDA’s Digital Health Push

06 Jan 2025

Contributed by Lukas

In this week’s Digital Health Roundup, Medtech Insight’s Marion Webb brings highlights from Deloitte’s 2025 Life Sciences Outlook Report with me...

The Future of Immunotherapy

06 Jan 2025

Contributed by Lukas

In this episode of the In Vivo podcast, Harvard immunologist and co-founder of early-stage biotech Corner Therapeutics, Jonathan Kagan, talks about ha...

An Insight into NASH

31 Dec 2024

Contributed by Lukas

Emma and Summer meet with Datamonitor Healthcare analyst Ken Hoang, to discuss the non-alcoholic steatohepatitis (NASH) treatment market

올해의 Top 5 글로벌 제약 뉴스 (Korean language podcast) - 27 December 2024

27 Dec 2024

Contributed by Lukas

Scrip이 선정한 2024년의 Top 5 글로벌 제약바이오 뉴스입니다. https://insights.citeline.com/scrip/business/deals/the-top-five-pharma-...

Scrip's Five Must-Know Things - 23 December 2024

23 Dec 2024

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the business week ended 20 December 2024. In this episode: Pfizer’s 2025 policy...

The Future Of eClinical Technology

19 Dec 2024

Contributed by Lukas

The Future Of eClinical Technology by Citeline

The Generics Bulletin Podcast: Highlights Of 2024

16 Dec 2024

Contributed by Lukas

Generics Bulletin's editorial team discusses key topics from the year, including the latest rankings of the GB Top 50, Amgen's surprise launch of a US...

Five Must-Know Things - 16 December 2024

16 Dec 2024

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the business week ended 13 December 2024. In this episode: a snapshot of the atop...

The Role of Site Networks & Why They Matter

10 Dec 2024

Contributed by Lukas

Learn how utilizing a site network can improve clinical trial efficiency and scalability, data quality, patient access and recruitment, resource optim...

Datamonitor Healthcare Podcast: Psychedelic Symposium at the University of Wisconsin-Madison

10 Dec 2024

Contributed by Lukas

Summer Colling speaks with Emma Wille about the Psychedelic Symposium at the University of Wisconsin-Madison and what the future of psychedelic therap...

Scrip's Five Must-Know Things - 10 December 2024

10 Dec 2024

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the business week ended 6 December 2024. In this episode: Zepbound bests Wegovy; ...

Arialys Therapeutics: Treating Autoimmune Neuropsychiatric Diseases

09 Dec 2024

Contributed by Lukas

In this episode of the In Vivo podcast, Peter Flynn, CEO of Arialys Therapeutics, discusses the exciting field of autoimmune neuropsychiatry and the c...

Drug Fix: COVID-19 Vaccine EUAs In Danger, DOGE And US FDA, New 340B Rebate Pricing Models

06 Dec 2024

Contributed by Lukas

Pink Sheet reporter and editors discuss potential threats to the COVID-19 vaccine pediatric indications under the Trump Administration (:24), the DOGE...

November 2024 Datamonitor Healthcare Podcast: Bispecific Antibodies in Oncology

05 Dec 2024

Contributed by Lukas

Emma and Summer meet with oncology analysts Neha Anand and David Dahan, to discuss an emerging class of drugs: bispecific antibodies.

Treating Rare Diseases With tRNA

04 Dec 2024

Contributed by Lukas

In this episode of the In Vivo podcast, Michelle Werner, CEO of Alltrna, discusses using tRNA as a therapeutic modality for rare diseases, including t...

Conference Catch-Up: BIO-Europe 2024

03 Dec 2024

Contributed by Lukas

Biopharma is evolving through collaboration, early-phase deal-making and innovation in precision medicine and AI. At BIO-Europe, Norstella's subject...

Scrip's Five Must-Know Things - 2 December 2024

02 Dec 2024

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the business week ended 29 November 2024. In this episode: Marks on Trump’s thr...

Scrip Awards Podcast, Ep2: 2024 Awards Preview & Verona Pharma Interview

28 Nov 2024

Contributed by Lukas

A preview of the 2024 Scrip Awards and an interview with last year’s Executive of the Year, David Zaccardelli, CEO of Verona Pharma.

Scrip's Five Must-Know Things - 25 November 2024

22 Nov 2024

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the business week ended 22 November 2024. In this episode: Novo’s semaglutide l...

Drug Fix: Trump’s Potential Impact On FDA User Fees, Dr. Oz’s Potential Impact On CMS

22 Nov 2024

Contributed by Lukas

Pink Sheet reporter and editors discuss concerns that the incoming administration could try to influence the upcoming FDA user fee reauthorization (:3...

Scrip's Five Must-Know Things - 18 November 2024

18 Nov 2024

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the business week ended 15 November 2024. In this episode: muscling into the obes...

Drug Fix: Trump Picks Robert F. Kennedy Jr. To Lead HHS, How Could He Disrupt FDA?

15 Nov 2024

Contributed by Lukas

Pink Sheet reporter and editors, and guest Michael McCaughan of Prevision Policy, continue the discussion of Donald Trump’s potential impact on the ...

Scrip M&A Podcast: Why Did Biopharma M&A Metrics Decline During Q2 And Q3

14 Nov 2024

Contributed by Lukas

Scrip senior writer Joseph Haas discusses recent merger-and-acquisition activity in the biopharma sector with Gerardo Ubaghs, CFO of Frontier Medicine...

Using AI To Predict Our Immune Responses

11 Nov 2024

Contributed by Lukas

In the latest episode of the In Vivo podcast, Noam Solomon, co-founder and CEO of Israeli-American biotech Immunai explains how his company is mapping...

Scrip's Five Must-Know Things - 11 November 2024

11 Nov 2024

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the business week ended 8 November 2024. In this episode: what Trump might mean f...

Conference Catch-Up: Navigating the Evolving CDMO Landscape

10 Nov 2024

Contributed by Lukas

Contract development and manufacturing organizations (CDMOs) are reshaping pharmaceutical production, playing a pivotal role in supply chain stability...

Drug Fix: How Will Trump’s Second Term Impact The US FDA?

08 Nov 2024

Contributed by Lukas

Pink Sheet reporter and editors discuss potential changes that the incoming Trump Administration could make on the FDA, as well as worries about polit...

Digital Health Roundup: GE HealthCare On AI At HLTH; EU AI Act, Click Therapeutics

07 Nov 2024

Contributed by Lukas

In this week’s Digital Health Roundup, Medtech Insight’s Marion Webb talks about her interview with GE HealthCare’s chief AI officer Parminder B...